46704 Federal Register / Vol. 86, No. 158 / Thursday, August 19, 2021 / Notices 

private or proprietary information such 

as Social Security numbers, medical 

information, inappropriate language, or 

duplicate/near duplicate examples of a 

mass-mail campaign. CDC will carefully 

consider all comments submitted in 

preparation of the final document. 

In 2017–2019 in the United States, 

65% of women aged 15–49 years used 

contraception; the most common 

contraceptive methods used were 

female sterilization, oral contraceptive 

pills, implants and intrauterine devices, 

and male condoms [1]. The majority 

(61%) of U.S. women aged 18–49 years 

have ongoing or potential need for 

contraceptive services [2]. Similarly, in 

2010–2016, about 60% of men aged 15– 

44 years in the United States needed 

family planning [3]. Equitable access to 

evidence-based, high quality care is 

critical to meeting the needs of persons 

seeking contraceptive services, 

improving reproductive autonomy, and 

reducing unintended pregnancy in the 

United States [2]. 

Since 2010, CDC has published 

evidence-based recommendations on 

contraception provision. These 

recommendations are intended to assist 

health care providers when they counsel 

patients about choice and use of 

contraceptive methods, with the goal of 

reducing medical barriers to 

contraception access. U.S. Medical 

Eligibility Criteria for Contraceptive Use, 

2016 (US MEC) comprises 

recommendations for the use of specific 

contraceptive methods by persons with 

certain characteristics or medical 

conditions, such as diabetes, 

hypertension, and being postpartum or 

breastfeeding [4]. U.S. Selected Practice 

Recommendations for Contraceptive 

Use, 2016 (US SPR) addresses common, 

yet sometimes complex, issues 

regarding initiation and use of specific 

contraceptive methods, such as 

examinations or tests needed before 

starting a method and management of 

side effects [5]. Both guidance 

documents are adapted from global 

guidance developed by the World 

Health Organization (WHO) and are 

based on review of the scientific 

evidence and consultation with national 

experts. CDC partners with other federal 

agencies and professional organizations 

in the development, dissemination, and 

implementation of the guidance 

documents to improve access to 

contraception and quality of family 

planning services. 

CDC is committed to ensuring that the 

US MEC and US SPR recommendations 

are reviewed and updated as new 

scientific evidence becomes available. 

Working with WHO, CDC continuously 

monitors peer-reviewed literature and 

updates recommendations as needed, 

with comprehensive reviews 

approximately every 5 years. CDC is 

currently planning for the next update 

of the US MEC and US SPR and will 

consider public comments when 

determining the scope of the guidance 

update. CDC is seeking feedback from 

health care providers, professional 

organizations, community-based 

organizations, organizations that seek to 

improve reproductive health, patient 

advocacy groups, and the public. 

The current US MEC may be found at 

the Supplementary Materials tab of the 

docket and at https://www.cdc.gov/ 

reproductivehealth/contraception/ 

mmwr/mec/summary.html. The current 

US SPR may be found at the 

Supplementary Materials tab of the 

docket and at https://www.cdc.gov/ 

reproductivehealth/contraception/ 

mmwr/spr/summary.html. 

References 

1. Daniels K, Abma JC. Current contraceptive 

status among women aged 15–49: United 

States, 2017–2019. NCHS Data Brief 

2020:388;1–8. 

2. Zapata LB, Pazol K, Curtis KM et al. Need 

for contraceptive services among women 

of reproductive age—45 jurisdictions, 

United States, 2017–2019. MMWR Morb 

Mortal Wkly Rep 2021;70:910–15. 

3. Marcell AV, Gibbs SE, Choiriyyah I et al. 

National needs of family planning among 

US men aged 15 to 44 years. Am J Public 

Health 2016:106;733–9. 

4. Curtis KM, Tepper NK, Jatlaoui TC, et al. 

U.S. medical eligibility criteria for 

contraceptive use, 2016. MMWR 

Recomm Rep 2016;65(RR–3):1–103. 

5. Curtis KM, Jatlaoui TC, Tepper NK, et al. 

U.S. selected practice recommendations 

for contraceptive use, 2016. MMWR 

Recomm Rep 2016;65(RR–4):1–66. 

Dated: August 16, 2021. 

Sandra Cashman, 

Executive Secretary, Centers for Disease 

Control and Prevention. 

[FR Doc. 2021–17818 Filed 8–18–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; Tribal 

Maternal, Infant, and Early Childhood 

Home Visiting Program: Guidance for 

Submitting an Annual Report to the 

Secretary (OMB #0970–0409) 

AGENCY: Office of Child Care, 

Administration for Children and 

Families, HHS. 

ACTION: Request for public comment. 

SUMMARY: The Administration for 

Children and Families (ACF), Office of 

Child Care (OCC) is requesting a 3-year 

extension of the Tribal Maternal, Infant, 

and Early Childhood Home Visiting 

(MIECHV) Program: Guidance for 

Submitting an Annual Report to the 

Secretary (OMB #0970–0409; expiration 

9/30/2021). There are minor updates to 

the annual guidance which reflects a 

change in timing for the due date of the 

final report. 

DATES: Comments due within 30 days of 

publication. OMB must make a decision 

about the collection of information 

between 30 and 60 days after 

publication of this document in the 

Federal Register. Therefore, a comment 

is best assured of having its full effect 

if OMB receives it within 30 days of 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

SUPPLEMENTARY INFORMATION: 

Description: Section 511(e)(8)(A) of Title 

V of the Social Security Act requires 

that grantees under the MIECHV 

program for states and jurisdictions 

submit an annual report to the Secretary 

of Health and Human Services regarding 

the program and activities carried out 

under the program, including such data 

and information as the Secretary shall 

require. Section 511(h)(2)(A) further 

states that the requirements for the 

MIECHV grants to tribes, tribal 

organizations, and urban Indian 

organizations are to be consistent, to the 

greatest extent practicable, with the 

requirements for grantees under the 

MIECHV program for states and 

jurisdictions. 

OCC, in collaboration with the Health 

Resources and Services Administration, 

Maternal and Child Health Bureau 

awarded grants for the Tribal MIECHV 

Program (Tribal Home Visiting) to 

support cooperative agreements to 

conduct community needs assessments; 

plan for and implement high-quality, 

culturally-relevant, evidence-based 

home visiting programs in at-risk tribal 

communities; establish, measure, and 

report on progress toward meeting 

performance measures in six 

legislatively-mandated benchmark 

areas; and conduct rigorous evaluation 

activities to build the knowledge base 

on home visiting among Native 

populations. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 158 / Thursday, August 19, 2021 / Notices 46705 

1Public Law 104–191, 110 Stat. 1936 (Aug 21, 

1996), available at https://www.congress.gov/104/ 

plaws/publ191/PLAW-104publ191.pdf. 

After the first grant year, Tribal Home 

Visiting grantees must comply with the 

requirement to submit an Annual Report 

to the Secretary that should feature 

activities carried out under the program 

during the past reporting period, and a 

final report to the Secretary during the 

final year of their grant. To assist 

grantees with meeting these 

requirements, ACF created guidance for 

grantees to use when writing their 

reports. The guidance specifies that 

grantees must address the following: 

• Update on Home Visiting Program 

Goals and Objectives 

• Update on the Implementation of 

Home Visiting Program in Targeted 

Community(ies) 

• Progress toward Meeting Legislatively 

Mandated Benchmark Requirements 

• Update on Rigorous Evaluation 

Activities 

• Home Visiting Program Continuous 

Quality Improvement (CQI) Efforts 

• Update on dissemination activities 

• Administration of Home Visiting 

Program 

• Technical Assistance Needs 

Previously, the guidance included 

information about both the annual and 

the final reports from grantees. This 

extension request includes updates to 

the guidance to make it specific to just 

the annual reports. Guidance specific to 

the final report will be submitted for 

review and approval by OMB in the 

future. A comment period will 

accompany that request. 

Respondents: Tribal Home Visiting 

Managers (information collection does 

not include direct interaction with 

individuals or families that receive the 

services). 

ANNUAL BURDEN ESTIMATES

Instrument 

Total 

number of 

respondents 

Annual 

number of 

responses per 

respondent 

Average 

burden hours 

per response 

Annual 

burden hours 

Annual Report to the Secretary ....................................................................... 23 1 25 575 

Estimated Total Annual Burden 

Hours: 575. 

Authority: Title V of the Social 

Security Act, Sections 511(e)(8)(A) and 

511(h)(2)(A). 

Mary B. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2021–17773 Filed 8–18–21; 8:45 am] 

BILLING CODE 4184–43–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting: National Committee on Vital 

and Health Statistics 

AGENCY: Centers for Disease Control and 

Prevention, Health and Human Services. 

ACTION: Notice of meeting. 

SUMMARY: Pursuant to the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (HHS) announces the following 

advisory committee meeting: National 

Committee on Vital and Health 

Statistics (NCVHS), Meeting of the Full 

Committee. This meeting is open to the 

public. The public is welcome to obtain 

the link to attend this meeting by 

following the instructions that will be 

posted here prior to the meeting: https:// 

ncvhs.hhs.gov/meetings/full-committeemeeting-8/. 

DATES: The meeting will be held 

Thursday, September 9, 2021: 10:30 

a.m.–5:00 p.m. EST and Friday, 

September 10, 2021: 10:30 a.m.–5:00 

p.m. EST 

ADDRESSES: Virtual open meeting. 

FOR FURTHER INFORMATION CONTACT: 

Substantive program information may 

be obtained from Rebecca Hines, MHS, 

Executive Secretary, NCVHS, National 

Center for Health Statistics, Centers for 

Disease Control and Prevention, 3311 

Toledo Road, Hyattsville, Maryland 

20782, or via electronic mail to vgh4@

cdc.gov; or by telephone (301) 458– 

4715. Summaries of meetings and a 

roster of Committee members are 

available on the home page of the 

NCVHS website, https://ncvhs.hhs.gov/, 

where further information including an 

agenda and instructions to access the 

broadcast of the meeting will be posted. 

Should you require reasonable 

accommodation, please contact the CDC 

Office of Equal Employment 

Opportunity on (770) 488–3210 as soon 

as possible. 

SUPPLEMENTARY INFORMATION: 

Purpose: As outlined in its Charter, 

the National Committee on Vital and 

Health Statistics assists and advises the 

Secretary of HHS on health data, data 

standards, statistics, privacy, national 

health information policy, and the 

Department’s strategy to best address 

those issues. This includes the adoption 

and implementation of transaction 

standards, unique identifiers, operating 

rules and code sets adopted under the 

Health Insurance and Portability Act of 

1996 (HIPAA).1 At this meeting, the 

Committee will receive updates from 

HHS officials, hold discussions on 

current health data policy topics, and 

discuss its work plan for the upcoming 

period. 

The Subcommittee on Standards will 

bring forward a letter that outlines a set 

of recommendations for HHS actions 

regarding the 11th Revision of the 

International Classification of Diseases 

(ICD–11) for the Committee’s 

consideration. In addition, the 

Subcommittee will update the full 

Committee on the August 25 Listening 

Session on Healthcare Standards 

Development, Adoption and 

Implementation, and how the input 

received from that session, as well as 

from an extended public comment 

period, is informing the Subcommittee’s 

‘‘Convergence 2.0’’ project. The 

Subcommittee on Privacy, 

Confidentiality & Security will update 

the Committee regarding the July 14 

hearing on Security in Healthcare and 

on its project to examine considerations 

for data collection and use during a 

public health emergency. The 

Committee also will discuss a potential 

project that would assess current 

standards and practices for reporting 

race and ethnicity data and sexual 

orientation and gender identity (SOGI) 

data. 

The Committee will reserve time for 

public comment toward the end of the 

schedule on both days. Meeting times 

and topics are subject to change. Please 

refer to the agenda posted at the NCVHS 

website for this meeting https://

ncvhs.hhs.gov/meetings/full-committeemeeting-8/ for any updates. 

Sharon Arnold, 

Associate Deputy Assistant Secretary for 

Planning and Evaluation, Science and Data 

Policy, Office of the Assistant Secretary for 

Planning and Evaluation. 

[FR Doc. 2021–17809 Filed 8–18–21; 8:45 am] 

BILLING CODE 4150–05–P 


lotter on DSK11XQN23PROD with NOTICES1